Mirador Therapeutics is making headlines with its impressive funding announcement, successfully raising $400 million in its latest investment round. Founded in 2024 and based in sunny San Diego, CA, Mirador is pioneering a new frontier in precision medicine, specifically targeting immunology and inflammation. The company’s innovative Mirador360™ precision development engine harnesses the latest breakthroughs in human genetics along with cutting-edge data science. This unique approach is designed to expedite the creation of tailored therapeutic solutions that address the specific needs of patients suffering from chronic immune-mediated inflammatory and fibrotic diseases. With this substantial funding boost, Mirador is poised to expand its research and development capabilities, focusing on advancing its pipeline of precision medicines that promise to revolutionize treatment options for patients facing these complex health challenges. The infusion of capital from top-tier life sciences investors signifies a strong vote of confidence in Mirador’s vision and technology. As the company embarks on its next phase of growth, the potential impact of its work could be transformative, offering hope and improved outcomes for individuals battling debilitating conditions. Mirador Therapeutics is not just pushing the boundaries of medical science; it is redefining the standard of care through precision-targeted therapies aimed at enhancing the quality of life for patients around the world.
Mirador Therapeutics Raises $400 Million in Series A Funding to Advance Precision Medicine for Chronic Inflammatory Diseases
Recently funded · $400.0M Series aPharmaceuticals
Get the full Mirador Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)
